Eagle Pharmaceuticals, Inc. Derivative, Gain (Loss) on Derivative, Net
Eagle Pharmaceuticals, Inc. reported Derivative, Gain (Loss) on Derivative, Net of $77.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2023-08-09
- Eagle Pharmaceuticals, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2023-06-30 was $0.00.
- Eagle Pharmaceuticals, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2023-03-31 was $77.00K, a 87.34% decline year-over-year.
- Eagle Pharmaceuticals, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Eagle Pharmaceuticals, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2022-09-30 was -$342.00K, a 618.18% decline year-over-year.
- Eagle Pharmaceuticals, Inc. derivative, gain (loss) on derivative, net for fiscal 2022 was -$962.00K, a 240.23% decline from fiscal 2021.
- Eagle Pharmaceuticals, Inc. derivative, gain (loss) on derivative, net for fiscal 2021 was $686.00K.
- Eagle Pharmaceuticals, Inc. derivative, gain (loss) on derivative, net for fiscal 2020 was $0.00.
- Eagle Pharmaceuticals, Inc. derivative, gain (loss) on derivative, net for fiscal 2019 was $0.00.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 12 month |
|---|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-08-09 | $77.00K 10-Q/A · filed 2023-08-09 | $77.00K derived: sum of 3 quarters · filed 2023-08-09 | -$265.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | $77.00K 10-Q · filed 2023-05-09 | $77.00K derived: sum of 2 quarters · filed 2023-05-09 | -$265.00K derived: sum of 3 quarters · filed 2023-05-09 | -$1.49M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$342.00K derived: sum of 2 quarters · filed 2023-03-23 | -$1.57M derived: sum of 3 quarters · filed 2023-08-09 | -$962.00K 10-K · filed 2023-03-23 |
| 2022-09-30 | -$342.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-09 | -$1.57M derived: sum of 2 quarters · filed 2023-08-09 | -$962.00K 10-Q · filed 2022-11-09 | -$530.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-06-30 | -$1.23M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-08-09 | -$620.00K 10-Q/A · filed 2023-08-09 | -$188.00K derived: sum of 3 quarters · filed 2023-08-09 | -$122.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $608.00K 10-Q · filed 2023-05-09 | $1.04M derived: sum of 2 quarters · filed 2023-05-09 | $1.11M derived: sum of 3 quarters · filed 2023-05-09 | $1.29M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $432.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $498.00K derived: sum of 2 quarters · filed 2023-03-23 | $686.00K derived: sum of 3 quarters · filed 2023-03-23 | $686.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $254.00K derived: sum of 2 quarters · filed 2022-11-09 | $254.00K 10-Q · filed 2022-11-09 | $2.80M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | $188.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $188.00K 10-Q · filed 2022-08-09 | $2.74M derived: sum of 3 quarters · filed 2023-03-23 | $188.00K derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | $2.55M derived: sum of 2 quarters · filed 2023-03-23 | $0.00 derived: sum of 3 quarters · filed 2023-03-23 | |
| 2020-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $0.00 derived: sum of 2 quarters · filed 2023-03-23 | $0.00 10-K · filed 2023-03-23 | |
| 2020-09-30 | -$2.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$2.55M 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-09 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-08 |